A novel research study has unveiled an unexpected influence of a 60-year-old diabetes drug, Metformin, on the human brain. The findings – which diverge significantly from past knowledge of the drug’s effect – could present new possibilities for addressing neurodegenerative diseases such as Alzheimer’s.
This discovery was made known in a study published last month in the international scientific journal, “Cell Reports”. Despite Metformin being used to manage type 2 diabetes for over six decades, these new findings have shocked and intrigued the medical fraternity all at once.
Metformin, the world’s most prescribed diabetes medication, works by lowering glucose production in the liver and improving the body’s insulin sensitivity. However, the recent study showed that Metformin also inhibits Complex 1, a crucial component of the mitochondria’s energy-making machinery present in the brain’s nerve cells. The inhibition sensitizes the brain to two major hormones, Insulin and Leptin, which control the brain’s energy metabolism.
This finding was unexpected, as it was previously believed that Metformin’s actions on Complex 1 were only specific to liver cells. Alarmingly, despite the drug’s wide usage, this potential effect on the brain had remained unexplored.
Medical researchers at the German Cancer Research Center (DKFZ) and Heidelberg University Hospital orchestrated the study. They report that the study exposes new paths “for the pharmacological manipulation of brain energy metabolism”.
“The finding of Metformin’s action on brain cells is quite surprising, given how long the drug has been in use. This novel function may shed new light on the drug’s therapeutic potential in neurodegenerative diseases including Alzheimer’s,” said Dr. Alessia Luoni, the study’s lead author.
Further, the study found that Metformin improved spatial memory and decreased anxiety-like behavior in mice. “The data obtained in mice is promising. However, more research is needed to determine long-term effects and translational significance to human patients,” added Dr. Luoni.
Metformin’s unexpected effect on the brain has already spurred online discussions. Numerous health forums and platforms have created spaces for dialogue, with both medical professionals and the broader public engaging in the discourse.
Leading online health platform, Healthline, covered the news, noting the unexpected benefits of these findings. Their recent blog post elucidated how Metformin, with its newfound impact, could potentially offer a novel approach to Alzheimer’s research. Similarly, the esteemed medical website, Medscape, published an article stressing the significance of these findings and the need for further research on the drug’s implications for brain health.
The news also made it to the popular diabetes-focused online community Diabetes.co.uk. Its members have shared mixed reactions, with some expressing optimism about potential advancements in Alzheimer’s research while others expressed concerns on the long-term effects of Metformin on brain health.
Despite its wide-ranging implications, experts urge caution in interpreting the study’s results. “Although the findings open up new avenues for research into neurogenerative diseases, it’s important to remember that these are early days,” said Dr. Johan Auwerx, a metabolic disease specialist at Ecole Polytechnique Federale de Lausanne in Switzerland. “Any potential change in the therapeutic use of Metformin based on these findings will definitely require more robust clinical trials,” he added.
If future research can replicate and augment these results, it may indeed change the way we view this six-decade-old diabetes drug. Until then, the surprise discovery of Metformin’s effect on the brain serves as a reminder of the vast, unexplored territories of medical science.
Original Source: https://www.sciencealert.com/after-60-years-diabetes-drug-revealed-to-unexpectedly-affect-the-brain
